Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including ...

An estimated 1 million people in the U.S. have been diagnosed with multiple sclerosis (MS)1 and it is likely between 30 and ...

A Falmouth senior netted back-to-back hat tricks, and players from Beverly/Danvers, Burlington, Milton, ...

Davis Cos. has unveiled its latest plan for the Waltham property after it scrapped a lab proposal and got hit with a lawsuit from the site’s former owner.

The North Chicago drugmaker says it could pay Xilio Therapeutics more than $2.1 billion in a collaboration and ...

Having kicked off the year with a T-cell engager deal, AbbVie has returned to the modality. | Having kicked off the year with ...

Xilio Therapeutics shares took flight in premarket trading Wednesday after the clinical-stage biotechnology company formed a potentially lucrative collaboration with AbbVie that includes an equity ...

AbbVie and Xilio Therapeutics have inked a collaboration and option-to-license agreement potentially worth more than $2 billion to clinical-stage biotechnology company Xilio.

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

See how former Stark County-area high school athletes are doing in college, including Luke Laubacher, Baila Bugara Ja’Corey ...

Fintel reports that on February 11, 2025, Deutsche Bank initiated coverage of Alkermes (NasdaqGS:ALKS) with a Buy recommendation. Analyst Price Forecast Suggests 8.79% Upside As of January 29, 2025, ...